Young Adult GIST Data
Pediatric GIST overview | Pediatric GIST Data | Pediatric GIST FAQs | Radiation Risks for Pediatric Patients |
Pediatric GIST References/Links | Pediatric GIST Presentations |
NIH Pediatric GIST Clinic
To join the Pediatric GIST listserv, go to: Pediatric GIST listserv
Reports - All under 30 | Carney's Triad | Pediatric GIST (under 18) | 18 to 24 years old | 25 to 30 years old
Life Raft Group Data
GIST in young adults may be similar or quite different than pediatric GIST (under 18) as the disease tends to transition from the pediatric type to the adult type. GISTs from patients in this age range may have wild-type GIST (and be more similiar to pediatric GIST), or they may have GISTs with KIT or PDGRA mutations and be more similar to adult GISTs. The response to treatment and the natural course of the disease may vary considerably as well.
| Patient ID | Gender |
Misdiagnosed Gist? | Original Cancer Diagnosis | Age at diagnosis |
Current age |
Years living w/GIST |
GIST Type |
Mutation | Location of Primary Tumor at Diagnosis | Current Treatment |
| PG-117 | F |
TRUE | Other | 19.2 |
32.2 |
12.9 |
GIST |
Stomach | Gleevec 400 mg | |
| PG-139 | F |
FALSE | 19.5 |
21.1 |
1.6 |
GIST |
Stomach | Neoadjuvant Gleevec 800 mg | ||
| PG-100 | F |
FALSE | 19.6 |
23.3 |
3.7 |
GIST |
Stomach | None | ||
| PG-138 | F |
TRUE | Other | 19.9 |
34.5 |
14.6 |
GIST |
Wildtype | Stomach | Sutent 31.5 mg (Alternates 37.5 & 25) |
| PG-108 | F |
TRUE | Other | 20.3 |
29.0 |
8.7 |
GIST |
Small Bowel | None, NED | |
| PG-102 | F |
FALSE | 20.6 |
25.4 at death |
5.2 |
GIST |
Stomach | Deceased | ||
| PG-105 | F |
FALSE | 21.0 |
25.5 |
4.5 |
GIST |
Wildtype | Stomach | Sutent 50 mg 4/2 schedule | |
| PG-130 | F |
FALSE | 21.1 |
21.8 |
0.6 |
GIST |
Stomach | Gleevec | ||
| PG-149 | F |
FALSE | 22.6 |
25.7 at death |
3.1 |
GIST |
Stomach | Deceased | ||
| PG-147 | F |
TRUE | LMS | 23.7 |
38.0 at death |
14.3 |
GIST |
Kit exon 11 | Stomach | Deceased |
| PG-135 | M |
FALSE | 18.0 |
19.6 |
1.6 |
GIST |
Wildtype | Stomach | None, NED | |
| PG-118 | M |
FALSE | 19.3 |
22.3 |
3.1 |
GIST |
Stomach | none, finished adjuvant Gleevec (1 yr) | ||
| PG-126 | M |
FALSE | 21.8 |
23.0 |
1.2 |
GIST |
Small Bowel | Gleevec 400 mg adjuvant | ||
| PG-116 | M |
FALSE | 23.1 |
24.9 at death |
1.7 |
GIST |
Liver | Deceased | ||
| PG-128 | M |
FALSE | 23.9 |
27.7 |
3.8 |
GIST |
Stomach | Gleevec + Rapamycin | ||
| PG-157 | M |
? |
23 at death |
? |
GIST |
Deceased | ||||
1. Gastrointestinal Stromal Tumors
in Children and Young Adults.
A Clinicopathologic, Molecular, and Genomic Study
of 15 Cases and Review of the Literature. J Pediatr Hematol Oncol Volume 27, Number 4, April 2005. Sonam Prakash, MD, Lisa Sarran, MS, Nicholas Socci, PhD,
Ronald P. DeMatteo, MD, Jonathan Eisenstat, MD, Alba M. Greco, MD,
Robert G. Maki, MD, PhD,{ Leonard H. Wexler, MD,k Michael P. LaQuaglia, MD,
Peter Besmer, PhD, and Cristina R. Antonescu, MD




